Literature DB >> 25475362

Autism spectrum disorder profile in neurofibromatosis type I.

Shruti Garg1, Ellen Plasschaert, Mie-Jef Descheemaeker, Susan Huson, Martine Borghgraef, Annick Vogels, D Gareth Evans, Eric Legius, Jonathan Green.   

Abstract

Neurofibromatosis Type 1 (NF1) is a common autosomal dominant single-gene disorder, in which the co-occurrence of autism spectrum disorder (ASD) has attracted considerable research interest recently with prevalence estimates of 21-40%. However, detailed characterization of the ASD behavioral phenotype in NF1 is still lacking. This study characterized the phenotypic profile of ASD symptomatology presenting in 4-16 year old children with NF1 (n = 36) using evidence from parent-rated Social Responsiveness Scale and researcher autism diagnostic observation Scale-2. Compared to IQ-matched reference groups of children with autism and ASD, the NF1 profile shows overall similarity but improved eye contact, less repetitive behaviors and better language skills.

Entities:  

Mesh:

Year:  2015        PMID: 25475362     DOI: 10.1007/s10803-014-2321-5

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  35 in total

1.  Childhood psychosis and neurofibromatosis--more than a coincidence?

Authors:  C Gillberg; C Forsell
Journal:  J Autism Dev Disord       Date:  1984-03

2.  Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

Authors:  Karin S Walsh; Jorge I Vélez; Peter G Kardel; Daniel M Imas; Maximilian Muenke; Roger J Packer; Francisco X Castellanos; Maria T Acosta
Journal:  Dev Med Child Neurol       Date:  2012-11-16       Impact factor: 5.449

Review 3.  Modeling cognitive dysfunction in neurofibromatosis-1.

Authors:  Kelly A Diggs-Andrews; David H Gutmann
Journal:  Trends Neurosci       Date:  2013-01-08       Impact factor: 13.837

4.  Neurofibromatosis type 1 and autism spectrum disorder.

Authors:  Shruti Garg; Jonathan Green; Kathy Leadbitter; Richard Emsley; Annukka Lehtonen; D Gareth Evans; Susan M Huson
Journal:  Pediatrics       Date:  2013-11-04       Impact factor: 7.124

5.  Social skills of children with neurofibromatosis type 1.

Authors:  Belinda Barton; Kathryn North
Journal:  Dev Med Child Neurol       Date:  2004-08       Impact factor: 5.449

6.  The effect of apamin, a small conductance calcium activated potassium (SK) channel blocker, on a mouse model of neurofibromatosis 1.

Authors:  Angy J Kallarackal; J Marc Simard; Aileen M Bailey
Journal:  Behav Brain Res       Date:  2012-09-13       Impact factor: 3.332

7.  Genomic imprinting and the expression of affect in Angelman syndrome: what's in the smile?

Authors:  Chris Oliver; Kate Horsler; Katy Berg; Gail Bellamy; Katie Dick; Emily Griffiths
Journal:  J Child Psychol Psychiatry       Date:  2007-06       Impact factor: 8.982

8.  Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample.

Authors:  Emily Simonoff; Andrew Pickles; Tony Charman; Susie Chandler; Tom Loucas; Gillian Baird
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-08       Impact factor: 8.829

9.  Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.

Authors:  Dalila Pinto; Elsa Delaby; Daniele Merico; Mafalda Barbosa; Alison Merikangas; Lambertus Klei; Bhooma Thiruvahindrapuram; Xiao Xu; Robert Ziman; Zhuozhi Wang; Jacob A S Vorstman; Ann Thompson; Regina Regan; Marion Pilorge; Giovanna Pellecchia; Alistair T Pagnamenta; Bárbara Oliveira; Christian R Marshall; Tiago R Magalhaes; Jennifer K Lowe; Jennifer L Howe; Anthony J Griswold; John Gilbert; Eftichia Duketis; Beth A Dombroski; Maretha V De Jonge; Michael Cuccaro; Emily L Crawford; Catarina T Correia; Judith Conroy; Inês C Conceição; Andreas G Chiocchetti; Jillian P Casey; Guiqing Cai; Christelle Cabrol; Nadia Bolshakova; Elena Bacchelli; Richard Anney; Steven Gallinger; Michelle Cotterchio; Graham Casey; Lonnie Zwaigenbaum; Kerstin Wittemeyer; Kirsty Wing; Simon Wallace; Herman van Engeland; Ana Tryfon; Susanne Thomson; Latha Soorya; Bernadette Rogé; Wendy Roberts; Fritz Poustka; Susana Mouga; Nancy Minshew; L Alison McInnes; Susan G McGrew; Catherine Lord; Marion Leboyer; Ann S Le Couteur; Alexander Kolevzon; Patricia Jiménez González; Suma Jacob; Richard Holt; Stephen Guter; Jonathan Green; Andrew Green; Christopher Gillberg; Bridget A Fernandez; Frederico Duque; Richard Delorme; Geraldine Dawson; Pauline Chaste; Cátia Café; Sean Brennan; Thomas Bourgeron; Patrick F Bolton; Sven Bölte; Raphael Bernier; Gillian Baird; Anthony J Bailey; Evdokia Anagnostou; Joana Almeida; Ellen M Wijsman; Veronica J Vieland; Astrid M Vicente; Gerard D Schellenberg; Margaret Pericak-Vance; Andrew D Paterson; Jeremy R Parr; Guiomar Oliveira; John I Nurnberger; Anthony P Monaco; Elena Maestrini; Sabine M Klauck; Hakon Hakonarson; Jonathan L Haines; Daniel H Geschwind; Christine M Freitag; Susan E Folstein; Sean Ennis; Hilary Coon; Agatino Battaglia; Peter Szatmari; James S Sutcliffe; Joachim Hallmayer; Michael Gill; Edwin H Cook; Joseph D Buxbaum; Bernie Devlin; Louise Gallagher; Catalina Betancur; Stephen W Scherer
Journal:  Am J Hum Genet       Date:  2014-04-24       Impact factor: 11.025

10.  Behavioral signatures related to genetic disorders in autism.

Authors:  Jacob As Vorstman; Patrick F Bolton; Hilgo Bruining; Marinus Jc Eijkemans; Martien Jh Kas; Sarah R Curran
Journal:  Mol Autism       Date:  2014-02-11       Impact factor: 7.509

View more
  27 in total

1.  RASopathies are associated with a distinct personality profile.

Authors:  Varoona Bizaoui; Jessica Gage; Rita Brar; Katherine A Rauen; Lauren A Weiss
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-04-16       Impact factor: 3.568

2.  Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.

Authors:  Thijs van der Vaart; André B Rietman; Ellen Plasschaert; Eric Legius; Ype Elgersma; Henriëtte A Moll
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

3.  Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types.

Authors:  Eungu Kang; Yoon-Myung Kim; Go Hun Seo; Arum Oh; Hee Mang Yoon; Young-Shin Ra; Eun Key Kim; Heyry Kim; Sun-Hee Heo; Gu-Hwan Kim; Mark J Osborn; Jakub Tolar; Han-Wook Yoo; Beom Hee Lee
Journal:  J Hum Genet       Date:  2019-11-28       Impact factor: 3.172

4.  Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis.

Authors:  Anita K Chisholm; Vicki A Anderson; Natalie A Pride; Stephanie Malarbi; Kathryn N North; Jonathan M Payne
Journal:  Neuropsychol Rev       Date:  2018-08-11       Impact factor: 7.444

5.  Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.

Authors:  Salmafatima S Abadin; Nancy L Zoellner; Melody Schaeffer; Bree Porcelli; David H Gutmann; Kimberly J Johnson
Journal:  J Pediatr       Date:  2015-05-28       Impact factor: 4.406

Review 6.  NMDA receptor activation regulates sociability by its effect on mTOR signaling activity.

Authors:  Jessica A Burket; Andrew D Benson; Amy H Tang; Stephen I Deutsch
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-20       Impact factor: 5.067

7.  Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).

Authors:  Stephanie M Morris; Maria T Acosta; Shruti Garg; Jonathan Green; Susan Huson; Eric Legius; Kathryn N North; Jonathan M Payne; Ellen Plasschaert; Thomas W Frazier; Lauren A Weiss; Yi Zhang; David H Gutmann; John N Constantino
Journal:  JAMA Psychiatry       Date:  2016-12-01       Impact factor: 21.596

8.  Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.

Authors:  Jennifer A Janusz; Bonita P Klein-Tasman; Jonathan M Payne; Pamela L Wolters; Heather L Thompson; Staci Martin; Peter de Blank; Nicole Ullrich; Allison Del Castillo; Maureen Hussey; Kristina K Hardy; Kristina Haebich; Tena Rosser; Mary Anne Toledo-Tamula; Karin S Walsh
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

9.  Sex bias in autism spectrum disorder in neurofibromatosis type 1.

Authors:  Shruti Garg; Hein Heuvelman; Susan Huson; Hannah Tobin; Jonathan Green
Journal:  J Neurodev Disord       Date:  2016-07-26       Impact factor: 4.025

10.  Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.

Authors:  Jannath Begum-Ali; Anna Kolesnik-Taylor; Isabel Quiroz; Luke Mason; Shruti Garg; Jonathan Green; Mark H Johnson; Emily J H Jones
Journal:  J Neurodev Disord       Date:  2021-05-28       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.